Search Results
Nov 10, 2025, 09:20 ET AtkinsRéalis Acquires U.S.-based C2AE Architecture and Engineering Firm
end-markets in Water, Transportation and Buildings & Places. "We are delighted to welcome C2AE to AtkinsRéalis," said Ian L. Edwards, President and CEO of AtkinsRéalis. "This acquisition strengthens our presence in the Upper Midwest, expands our capabilities in key growth end-markets
More news about: AtkinsRéalis
Nov 10, 2025, 09:15 ET TGH Rehabilitation Hospital Is Recognized by Newsweek as One of the Nation's Top Physical Rehabilitation Centers
not-for-profit academic health system, is one of the largest hospitals in America and delivers world-class care as the Tampa Bay region's only center for Level l trauma and comprehensive burn care. The system's hospitals include Tampa General Hospital, Tampa General Rehabilitation Hospital, and Tampa General Behavioral
More news about: Tampa General Hospital
Nov 10, 2025, 09:00 ET Partner Robotics raises Series A funding to deploy robots on construction sites worldwide
strategy. For now, Partner Robotics is focusing on two products: Floor Tile Paving Robot P900 and Intelligent Scribing Robot L3000. Both address specific challenges and fit into what the company describes as a "high-value and feasible" product roadmap, with the long-term aim of
More news about: Partner Robotics
Nov 10, 2025, 09:00 ET S&P Global Adds Robert Moritz to its Board of Directors
seats, including at SUNY-Oswego College Foundation, his alma mater. "We're thrilled to welcome Bob to our Board," said Martina L. Cheung, President and CEO, S&P Global. "He brings extensive global experience and unique perspectives on the opportunities and risks facing global
More news about: S&P Global
Nov 10, 2025, 09:00 ET Parkinson's Foundation Requesting Applications for 2026 Community Grants
program supported 90 programs in 38 states that provide services for people living in areas underserved by existing care programs and resources," said John L. Lehr, President and CEO of the Parkinson's Foundation. "With this funding, we are proud to continue showcasing our commitment to making an impact in
More news about: Parkinson's Foundation
Nov 10, 2025, 09:00 ET Rapid zalunfiban treatment at 1st point of medical contact lowered risk of more severe heart damage in combination with other serious heart-attack complications
[email protected] 1 Reddy A, Ganti L, Banerjee A, Banerjee P. Continuous quality improvement for prehospital STEMI improved triage rates and achievement of gold standard < 90-min EMS-to-balloon
More news about: CeleCor Therapeutics, Inc.
Nov 10, 2025, 08:50 ET Parker Waichman LLP Files Lawsuit on behalf of Florida Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic
Firm filed a lawsuit on behalf of a Florida resident who developed NAION after taking Ozempic. See Martin v. Novo Nordisk Inc., Docket No: MID-L-007920-25.
More news about: Parker Waichman LLP
Nov 10, 2025, 08:46 ET Novo Nordisk's Wegovy® (semaglutide 2.4 mg) was associated with liver health-related benefits not solely based on weight loss in adult patients with MASH with liver scarring, according to a new post hoc analysis
Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology.
More news about: NOVO NORDISK INC.
Nov 10, 2025, 08:45 ET Novo Nordisk's Wegovy® (semaglutide 2.4 mg) was associated with liver health-related benefits not solely based on weight loss in adult patients with MASH with liver scarring, according to a new post hoc analysis
Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology.
More news about: NOVO NORDISK INC.
Nov 10, 2025, 08:33 ET AION UT, fue presentado oficialmente en Macao, GAC implementa profundamente la "Macao ACTION" para acelerar la globalización ecológica
que las sofisticadas configuraciones tecnológicas, como la interacción de voz inteligente y el sistema avanzado de asistencia al conductor de nivel L2, superaban las expectativas. Los medios de comunicación especializados en automoción de Macao afirmaron que el AION UT ofrece un rendimiento excepcional
More news about: GAC
Nov 10, 2025, 08:30 ET Brii Biosciences Presents Late-Breaking Data from Ongoing Phase 2 ENSURE Study at AASLD 2025, Reinforcing BRII-179's Potential as a Curative Treatment for Chronic Hepatitis B
BRII-179 anti-HBs responders or non-responders based on their peak hepatitis B surface antibody (anti-HBs) levels during the prior study (≥10 IU/L or <10 IU/L, respectively). EOT data from Cohort 4 were previously
More news about: Brii Biosciences Limited
Nov 10, 2025, 08:29 ET AION UT offiziell in Macau eingeführt und GAC setzt „Macau ACTION" konsequent um, um die ökologische Globalisierung voranzutreiben
Meinung, dass die umfangreiche technische Ausstattung, wie die intelligente Sprachsteuerung und das fortschrittliche Fahrerassistenzsystem der Stufe L2, ihre Erwartungen übertroffen habe. Die Fachmedien für Automobiltechnik in Macau bestätigten, dass der AION UT in Bezug auf Design, Raumausnutzung und
More news about: GAC
Nov 10, 2025, 08:22 ET Lors du lancement officiel d'AION UT à Macao, GAC met en œuvre « Macao ACTION » pour accélérer la mondialisation écologique
estimé que les riches configurations technologiques, telles que l'interaction vocale intelligente et le système avancé d'aide à la conduite de niveau L2, dépassaient les attentes. La presse automobile professionnelle de Macao a déclaré que l'AION UT est remarquable en termes de design, d'espace et d'intelligence,
More news about: GAC
Nov 10, 2025, 08:00 ET Tiumbio to Present First Clinical Data for Dual TGF-β/VEGF Inhibitor Tosposertib (TU2218) at SITC 2025, "Robust Response Rate"
1L : Response rates overall (N=11) : 72.7% (8/11), including 6 confirmed partial responses (PRs) and 2 unconfirmed PRs2L+ : Response rates overall (N=6) : 66.7% (4/6), including 3 confirmed partial response (PRs) and 1 unconfirmed PRsResponses observed across PD-L1 levels (CPS
More news about: TiumBio
Nov 10, 2025, 08:00 ET Johnson & Johnson lança plataforma VARIPULSE™ no Brasil e avança no tratamento da fibrilação atrial
Arrhythm Electrophysiol. 2023;16(3):e011780. doi:10.1161/CIRCEP.122.011780 pg 4 ii Reddy VY, Calkins H, Mansour M, Wazni O, Di Biase L, Bahu M, Newton D, Liu CF, Sauer WH, Goyal S, Iyer V, Nair D, Athill C, Hussein A, Whalen P, Melby D, Natale A; AdmIRE Trial Investigators. Pulsed Field
More news about: Johnson & Johnson MedTech
Nov 10, 2025, 07:30 ET ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update
with 2L+ DLBCL once the pre-specified number of progression-free survival (PFS) events is reached and data are available. Assuming positive results, a supplemental Biologics License Application (sBLA) submission to regulatory authorities will follow, with potential confirmatory approval in 2L+ DLBCL
More news about: ADC Therapeutics SA
Nov 10, 2025, 07:30 ET CORVEX TO GO PUBLIC IN ALL-STOCK MERGER WITH MOVANO, CREATING A PURE-PLAY PLATFORM FOR SECURE AI INFRASTRUCTURE AND HIGH-PERFORMANCE INFERENCE
exclusive financial advisor to Corvex on the Merger and placement agent to Movano on the Bridge Financing. Jones is serving as an advisor to Corvex. K&L Gates LLP is serving as legal counsel to Movano. DLA Piper LLP (US) is serving as legal counsel to Corvex. Goodwin Procter LLP is serving as legal
More news about: Movano
Nov 10, 2025, 07:00 ET Yueda Digital Holding Announces One-for-One Hundred Reverse Share Split and Share Consolidation
Class A ordinary shares will trade on the Nasdaq Capital Market on a split-adjusted basis, under the same symbol "YDKG" but under a new CUSIP number, G0137L110. As a result of the Reverse Share Split and Share Consolidation, each 100 issued and outstanding Class A ordinary shares of
More news about: Yueda Digital Holding
Nov 10, 2025, 07:00 ET Compugen Reports Third Quarter 2025 Results
10.5 months in patients who derived clinical benefit. The data also showed that COM701 biology is differentiated, reflected in responses seen across PD-L1 expression levels. This data is important as it characterized responding patients, guiding the design of our ongoing blinded and randomized MAIA-ovarian
More news about: Compugen Ltd.
Nov 10, 2025, 07:00 ET Powerfleet Reports Q2 FY26 Financial Results with 7% Quarterly Sequential Increase in Total Revenue
margin expansion, highlight continued momentum and resilience amid evolving macroeconomic conditions. We also delivered clear leverage across the P&L, with the rapid realization of our synergy programs driving meaningful bottom-line strength." "These results underscore the
More news about: Powerfleet
Nov 10, 2025, 06:59 ET Aircraft Heat Exchanger Market worth $6.45 billion by 2030 - Exclusive Report by MarketsandMarkets™
Market by End Use (Broadband, Voice Communication, Private Network), Application (Maritime, Aviation, Automotive, Government & Defense), Frequency (L, S, C, X, Ku, Ka, Multi-Band), Network (Standard VSAT, USAT) and Region - Global Forecast to 2030
More news about: MarketsandMarkets
Nov 10, 2025, 06:35 ET DJI Agriculture presenta los agras T100, T70P y T25P en Agritechnica 2025 en Hannover
T100 Diseñado para productores comerciales a gran escala, el Agras T100 puede transportar una carga máxima de 100 L para pulverización, 150 L para esparcimiento o 80 kg para levantamiento. En comparación con su predecesor, es el doble de eficiente para la pulverización de grandes
More news about: DJI
Nov 10, 2025, 06:28 ET DJI Agriculture stellt Agras T100, T70P und T25P auf der Agritechnica 2025 in Hannover vor
Die Agras T100 wurde für die großflächige kommerzielle Landwirtschaft konzipiert und kann eine maximale Nutzlast von 100 l zum Sprühen, 150 l zum Streuen oder 80 kg zum Heben transportieren. Im Vergleich zu ihrem Vorgängermodell ist sie beim Sprühen großer Mengen doppelt so effizient
More news about: DJI
Nov 10, 2025, 06:18 ET DJI Agriculture dévoile Agras T100, T70P et T25P à Agritechnica 2025 à Hanovre
Conçu pour les producteurs commerciaux à grande échelle, Agras T100 peut transporter une charge utile maximale de 100 L pour la pulvérisation, 150 L pour la dispersion ou 80 kg pour le levage. Par rapport à son prédécesseur, il est deux fois plus efficace pour la pulvérisation à grand
More news about: DJI
Nov 10, 2025, 06:03 ET DJI Agriculture Unveils Agras T100, T70P, and T25P at Agritechnica 2025 in Hannover
T100 Designed for large-scale commercial growers, the Agras T100 can carry a maximum payload of 100 L for spraying, 150 L for spreading, or 80 kg for lifting. Compared to its predecessor, it is twice as efficient for high-volume spraying and faster for large-capacity
More news about: DJI